GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Hspa5 | decreases expression | ISO | Hspa5 (Mus musculus) | 6480464 | CTD | deoxynivalenol results in decreased expression of HSPA5 mRNA | PMID:10652249 | Hspa5 | decreases expression | ISO | HSPA5 (Homo sapiens) | 6480464 | CTD | deoxynivalenol results in decreased expression of HSPA5 mRNA | PMID:20682335 PMID:24356939 | Hspa5 | increases phosphorylation | ISO | Hspa5 (Mus musculus) | 6480464 | CTD | deoxynivalenol results in increased phosphorylation of HSPA5 protein | PMID:23811945 | Hspa5 | multiple interactions | ISO | Hspa5 (Mus musculus) | 6480464 | CTD | calpain inhibitor III inhibits the reaction [deoxynivalenol results in increased degradation of HSPA5 protein]; deoxynivalenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA5 mRNA]; deoxynivalenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA5 protein]; deoxynivalenol results in increased degradation of and results in decreased expression of HSPA5 protein; phenylalanyl-glycyl-NHO-Bz inhibits the reaction [deoxynivalenol results in increased degradation of HSPA5 protein] | PMID:10652249 PMID:19336499 | |
Go Back to source page | Continue to Ontology report |